Answers are grounded in this paper and cite their sources.
Feasibility analysis demonstrates sustainable molybdenum-99 production from technetium-99 waste, highlighting an alternative supply pathway for nuclear medicine.
Tc resource (Product Catalog; Ando and Takano, 1999; Oigawa, 2014), and the advantages of using muon nuclear-capture reactions for radioisotope production.
No takes yet. Share an insight, caveat, or question.
Matsuzaki et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: